Germline predisposition in myeloid neoplasms: Unique genetic and clinical features of GATA2 deficiency and SAMD9/SAMD9L syndromes

[1]  M. Boerries,et al.  Synonymous GATA2 mutations result in selective loss of mutated RNA and are common in patients with GATA2 deficiency , 2020, Leukemia.

[2]  Nicholas D. Camarda,et al.  Distinct genetic pathways define pre-leukemic and compensatory clonal hematopoiesis in Shwachman-Diamond syndrome , 2020, bioRxiv.

[3]  Anna L. Brown,et al.  A synonymous GATA2 variant underlying familial myeloid malignancy with striking intrafamilial phenotypic variability , 2020, British journal of haematology.

[4]  Anna L. Brown,et al.  Secondary leukemia in patients with germline transcription factor mutations (RUNX1, GATA2, CEBPA). , 2020, Blood.

[5]  E. Bresnick,et al.  Breaking the spatial constraint between neighboring zinc fingers: a new germline mutation in GATA2 deficiency syndrome , 2020, Leukemia.

[6]  Y. Etani,et al.  MIRAGE syndrome caused by a novel missense variant (p.Ala1479Ser) in the SAMD9 gene , 2020, Human Genome Variation.

[7]  Angela N. Viaene,et al.  The Neuropathology of MIRAGE Syndrome. , 2020, Journal of neuropathology and experimental neurology.

[8]  I. Touw,et al.  RUNX1 Mutations in the Leukemic Progression of Severe Congenital Neutropenia , 2020, Molecules and cells.

[9]  D. Linch,et al.  In trans early mosaic mutational escape and novel phenotypic features of germline SAMD9 mutation , 2020, British journal of haematology.

[10]  Andrew J. Oler,et al.  Distinct interferon signatures and cytokine patterns define additional systemic autoinflammatory diseases. , 2019, The Journal of clinical investigation.

[11]  G. Huet,et al.  Familial myeloid malignancies with germline TET2 mutation , 2019, Leukemia.

[12]  S. Savage,et al.  An update on the biology and management of dyskeratosis congenita and related telomere biology disorders , 2019, Expert review of hematology.

[13]  B. Lambrecht,et al.  GATA2 deficiency and haematopoietic stem cell transplantation: challenges for the clinical practitioner , 2019, British journal of haematology.

[14]  V. Zhang,et al.  Mutations in both SAMD9 and SLC19A2 genes caused complex phenotypes characterized by recurrent infection, dysphagia and profound deafness – a case report for dual diagnosis , 2019, BMC Pediatrics.

[15]  T. Kalina,et al.  Novel SAMD9 Mutation in a Patient With Immunodeficiency, Neutropenia, Impaired Anti-CMV Response, and Severe Gastrointestinal Involvement , 2019, Front. Immunol..

[16]  Y. Morel,et al.  Reversion SAMD9 Mutations Modifying Phenotypic Expression of MIRAGE Syndrome and Allowing Inheritance in a Usually de novo Disorder , 2019, Front. Endocrinol..

[17]  L. Wartman,et al.  Fifty Shades of GATA2 Mutation: A Case of Plasmablastic Lymphoma, Nontuberculous Mycobacterial Infection, and Myelodysplastic Syndrome. , 2019, Clinical lymphoma, myeloma & leukemia.

[18]  S. Edkins,et al.  Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia , 2019, Stem cell reports.

[19]  I. Ahmed,et al.  Outcomes of Hematopoietic Cell Transplantation in Patients with Germline SAMD9/SAMD9L Mutations , 2019, Biology of Blood and Marrow Transplantation.

[20]  Anna L. Brown,et al.  A novel germline SAMD9L mutation in a family with ataxia-pancytopenia syndrome and pediatric acute lymphoblastic leukemia , 2019, Haematologica.

[21]  M. Kamboj,et al.  A novel SAMD9 variant identified in patient with MIRAGE syndrome: Further defining syndromic phenotype and review of previous cases , 2019, Pediatric blood & cancer.

[22]  E. Pitkänen,et al.  ERCC6L2 defines a novel entity within inherited acute myeloid leukemia. , 2019, Blood.

[23]  E. Mengen,et al.  A Rare Etiology of 46,XY Disorder of Sex Development and Adrenal Insufficiency: A Case of MIRAGE Syndrome Caused by Mutations in the SAMD9 Gene , 2019, Journal of clinical research in pediatric endocrinology.

[24]  E. Mengen,et al.  A Rare Etiology of 46, XY Disorder of Sex Development and Adrenal Insufficiency: A case of MIRAGE syndrome caused by mutations in SAMD9 gene , 2019, Journal of Clinical Research in Pediatric Endocrinology.

[25]  K. Calvo,et al.  Inherited thrombocytopenia and platelet disorders with germline predisposition to myeloid neoplasia , 2019, International journal of laboratory hematology.

[26]  G. Webersinke,et al.  Somatic mosaic monosomy 7 and UPD7q in a child with MIRAGE syndrome caused by a novel SAMD9 mutation , 2019, Pediatric blood & cancer.

[27]  M. Axelsson,et al.  Leukoencephalopathia, demyelinating peripheral neuropathy and dural ectasia explained by a not formerly described de novo mutation in the SAMD9L gene, ends 27 years of investigations – a case report , 2019, BMC Neurology.

[28]  Namhee Kim,et al.  Monozygotic twins with shared de novo GATA2 mutation but dissimilar phenotypes due to differential promoter methylation , 2019, Leukemia & lymphoma.

[29]  J. Orange,et al.  Myeloid malignancies with somatic GATA2 mutations can be associated with an immunodeficiency phenotype , 2019, Leukemia & lymphoma.

[30]  S. Holland,et al.  MDS-associated mutations in germline GATA2 mutated patients with hematologic manifestations. , 2019, Leukemia research.

[31]  C. Niemeyer.  Pediatric MDS Including Refractory Cytopenia and Juvenile Myelomonocytic Leukemia , 2018, The EBMT Handbook.

[32]  M. Wlodarski,et al.  SAMD9 and SAMD9L Germline Disorders in Patients Enrolled in Studies of the European Working Group of MDS in Childhood (EWOG-MDS): Prevalence, Outcome, Phenotype and Functional Characterisation , 2018, Blood.

[33]  L. G. Oestgaard.  Longer Distance to a Specialized Treatment Center Does Not Adversely Affect Access to Treatment or Outcome in Acute Myeloid Leukemia: A National Population-Based Cohort Study , 2018, Blood.

[34]  R. Greil,et al.  Pomalidomide (POM) and Low-Dose Dexamethasone (LoDEX) in Relapsed/Refractory Multiple Myeloma (RRMM): Analysis of Real World Data from an Ongoing, National, Multi-Center, Non-Interventional Study , 2018, Blood.

[35]  V. Bezzerri,et al.  Shwachman-Diamond Syndrome: Molecular Mechanisms and Current Perspectives , 2018, Molecular Diagnosis & Therapy.

[36]  Yukichi Tanaka,et al.  MIRAGE syndrome is a rare cause of 46,XY DSD born SGA without adrenal insufficiency , 2018, PloS one.

[37]  T. Walsh,et al.  A novel disease-causing synonymous exonic mutation in GATA2 affecting RNA splicing. , 2018, Blood.

[38]  B. Ko,et al.  GATA2 zinc finger 1 mutations are associated with distinct clinico-biological features and outcomes different from GATA2 zinc finger 2 mutations in adult acute myeloid leukemia , 2018, Blood Cancer Journal.

[39]  M. Loh,et al.  Germline SAMD9 and SAMD9L mutations are associated with extensive genetic evolution and diverse hematologic outcomes. , 2018, JCI insight.

[40]  T. Vulliamy,et al.  Genome instability is a consequence of transcription deficiency in patients with bone marrow failure harboring biallelic ERCC6L2 variants , 2018, Proceedings of the National Academy of Sciences.

[41]  E. Haralambieva,et al.  Allogeneic hematopoietic cell transplantation in patients with GATA2 deficiency—a case report and comprehensive review of the literature , 2018, Annals of Hematology.

[42]  J. Casanova,et al.  Lethal Influenza in Two Related Adults with Inherited GATA2 Deficiency , 2018, Journal of Clinical Immunology.

[43]  Thomas E. Hughes,et al.  Allogeneic Hematopoietic Stem Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen. , 2018, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[44]  T. Marafioti,et al.  Can somatic GATA2 mutation mimic germ line GATA2 mutation? , 2018, Blood advances.

[45]  J. Fitzgibbon,et al.  GATA2 monoallelic expression underlies reduced penetrance in inherited GATA2-mutated MDS/AML , 2018, Leukemia.

[46]  A. Gennery,et al.  In vivo T-depleted reduced-intensity transplantation for GATA2-related immune dysfunction. , 2018, Blood.

[47]  J. Ko,et al.  A case of an infant suspected as IMAGE syndrome who were finally diagnosed with MIRAGE syndrome by targeted Mendelian exome sequencing , 2018, BMC Medical Genetics.

[48]  H. Cavé,et al.  Natural history of GATA2 deficiency in a survey of 79 French and Belgian patients , 2018, Haematologica.

[49]  J. Soulier,et al.  A landscape of germ line mutations in a cohort of inherited bone marrow failure patients. , 2018, Blood.

[50]  W. Ji,et al.  A novel SAMD9 mutation causing MIRAGE syndrome: An expansion and review of phenotype, dysmorphology, and natural history , 2018, American journal of medical genetics. Part A.

[51]  Y. Xiang,et al.  A paralogous pair of mammalian host restriction factors form a critical host barrier against poxvirus infection , 2018, PLoS pathogens.

[52]  G. Wertheim,et al.  Poor outcome with hematopoietic stem cell transplantation for bone marrow failure and MDS with severe MIRAGE syndrome phenotype. , 2018, Blood advances.

[53]  M. Boerries,et al.  Constitutional SAMD9L mutations cause familial myelodysplastic syndrome and transient monosomy 7 , 2017, Haematologica.

[54]  Morgan Park,et al.  Somatic mosaicism of an intragenic FANCB duplication in both fibroblast and peripheral blood cells observed in a Fanconi anemia patient leads to milder phenotype , 2017, Molecular genetics & genomic medicine.

[55]  M. Schuelke,et al.  Two patients with MIRAGE syndrome lacking haematological features: role of somatic second-site reversion SAMD9 mutations , 2017, Journal of Medical Genetics.

[56]  T. Hasegawa,et al.  Genetic defects in pediatric-onset adrenal insufficiency in Japan. , 2017, European journal of endocrinology.

[57]  Anna L. Brown,et al.  Differential effects on gene transcription and hematopoietic differentiation correlate with GATA2 mutant disease phenotypes , 2017, Leukemia.

[58]  M. Wlodarski,et al.  Heterogeneity of GATA2-related myeloid neoplasms , 2017, International Journal of Hematology.

[59]  K. Welte,et al.  Severe congenital neutropenias , 2017, Nature Reviews Disease Primers.

[60]  S. Raimondi,et al.  Germline SAMD9 Mutation in Siblings with Monosomy 7 and Myelodysplastic Syndrome , 2017, Leukemia.

[61]  H. Cavé,et al.  Genotype and phenotype spectrum of NRAS germline variants , 2017, European Journal of Human Genetics.

[62]  T. Fioretos,et al.  Gain-of-function SAMD9L mutations cause a syndrome of cytopenia, immunodeficiency, MDS, and neurological symptoms. , 2017, Blood.

[63]  Matthew Collin,et al.  GATA2 deficiency and related myeloid neoplasms , 2017, Seminars in hematology.

[64]  M. Wlodarski,et al.  Introduction: Genetic syndromes predisposing to myeloid neoplasia. , 2017, Seminars in hematology.

[65]  G. Kokai,et al.  Somatic mutations and progressive monosomy modify SAMD9-related phenotypes in humans , 2017, The Journal of clinical investigation.

[66]  M. Vikkula,et al.  GATA2 null mutation associated with incomplete penetrance in a family with Emberger syndrome , 2017, Hematology.

[67]  Jia Liu,et al.  An interaction domain in human SAMD9 is essential for myxoma virus host-range determinant M062 antagonism of host anti-viral function. , 2017, Virology.

[68]  M. Wlodarski,et al.  Mutational landscape in children with myelodysplastic syndromes is distinct from adults: specific somatic drivers and novel germline variants , 2017, Leukemia.

[69]  S. Holland,et al.  Somatic mutations in children with GATA2-associated myelodysplastic syndrome who lack other features of GATA2 deficiency. , 2017, Blood advances.

[70]  J. Klco,et al.  The genomic landscape of pediatric myelodysplastic syndromes , 2016, Nature Communications.

[71]  Henry Yang,et al.  Mutational profiling of a MonoMAC syndrome family with GATA2 deficiency , 2016, Leukemia.

[72]  J. Soulier,et al.  How I treat MDS and AML in Fanconi anemia. , 2016, Blood.

[73]  Deborah Nickerson,et al.  Ataxia-Pancytopenia Syndrome Is Caused by Missense Mutations in SAMD9L. , 2016, American journal of human genetics.

[74]  L. Faivre,et al.  Altered chemotactic response to CXCL12 in patients carrying GATA2 mutations , 2016, Journal of leukocyte biology.

[75]  T. Kalina,et al.  Loss of B cells and their precursors is the most constant feature of GATA-2 deficiency in childhood myelodysplastic syndrome , 2016, Haematologica.

[76]  H. Okano,et al.  SAMD9 mutations cause a novel multisystem disorder, MIRAGE syndrome, and are associated with loss of chromosome 7 , 2016, Nature Genetics.

[77]  D. Adams,et al.  Single-gene association between GATA-2 and autoimmune hepatitis: A novel genetic insight highlighting immunologic pathways to disease , 2016, Journal of hepatology.

[78]  K. Welte,et al.  Role of CSF3R mutations in the pathomechanism of congenital neutropenia and secondary acute myeloid leukemia , 2016, Annals of the New York Academy of Sciences.

[79]  M. Wlodarski,et al.  Prevalence, clinical characteristics, and prognosis of GATA2-related myelodysplastic syndromes in children and adolescents. , 2016, Blood.

[80]  H. Cavé,et al.  Acute lymphoblastic leukemia in the context of RASopathies. , 2016, European journal of medical genetics.

[81]  Q. Wang,et al.  Exome sequencing identifies highly recurrent somatic GATA2 and CEBPA mutations in acute erythroid leukemia , 2015, Leukemia.

[82]  Lin Wu,et al.  miR-96 induces cisplatin chemoresistance in non-small cell lung cancer cells by downregulating SAMD9 , 2015, Oncology letters.

[83]  J. Tchinda,et al.  Somatic Genetic and Epigenetic Architecture of Myelodysplastic Syndromes Arising from GATA2 Deficiency , 2015 .

[84]  Junpeng Deng,et al.  Structural basis for antagonizing a host restriction factor by C7 family of poxvirus host-range proteins , 2015, Proceedings of the National Academy of Sciences.

[85]  J. Gribben,et al.  Disease evolution and outcomes in familial AML with germline CEBPA mutations. , 2015, Blood.

[86]  S. Meyer,et al.  Fanconi anaemia: genetics, molecular biology, and cancer – implications for clinical management in children and adults , 2015, Clinical genetics.

[87]  S. Miyano,et al.  GATA2 and secondary mutations in familial myelodysplastic syndromes and pediatric myeloid malignancies , 2015, Haematologica.

[88]  S. Miyano,et al.  Inherited and Somatic Defects in DDX41 in Myeloid Neoplasms. , 2015, Cancer cell.

[89]  M. Odero,et al.  GATA2 Germline Mutations Impair GATA2 Transcription, Causing Haploinsufficiency: Functional Analysis of the p.Arg396Gln Mutation , 2015, The Journal of Immunology.

[90]  H. Scott,et al.  Characterisation of a compound in-cis GATA2 germline mutation in a pedigree presenting with myelodysplastic syndrome/acute myeloid leukemia with concurrent thrombocytopenia , 2015, Leukemia.

[91]  Chieh-Yu Liu,et al.  GATA2 mutations in patients with acute myeloid leukemia-paired samples analyses show that the mutation is unstable during disease evolution , 2015, Annals of Hematology.

[92]  David A. Williams,et al.  Germline ETV6 mutations in familial thrombocytopenia and hematologic malignancy , 2015, Nature Genetics.

[93]  David A. Williams,et al.  Genomic analysis of bone marrow failure and myelodysplastic syndromes reveals phenotypic and diagnostic complexity , 2015, Haematologica.

[94]  P. Ljungman,et al.  Allogeneic Hematopoietic Cell Transplantation for GATA2 Deficiency in a Patient With Disseminated Human Papillomavirus Disease. , 2014, Transplantation.

[95]  Thomas E. Hughes,et al.  Nonmyeloablative allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. , 2014, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[96]  C. Niemeyer.  RAS diseases in children , 2014, Haematologica.

[97]  L. Dotta,et al.  Primary immunodeficiencies appearing as combined lymphopenia, neutropenia, and monocytopenia. , 2014, Immunology letters.

[98]  M. Nagasaki,et al.  Identification of acquired mutations by whole-genome sequencing in GATA-2 deficiency evolving into myelodysplasia and acute leukemia , 2014, Annals of Hematology.

[99]  N. McGovern,et al.  The evolution of cellular deficiency in GATA2 mutation. , 2014, Blood.

[100]  J. Orange,et al.  GATA2 deficiency: a protean disorder of hematopoiesis, lymphatics, and immunity. , 2014, Blood.

[101]  S. Holland,et al.  Acquired ASXL1 mutations are common in patients with inherited GATA2 mutations and correlate with myeloid transformation , 2014, Haematologica.

[102]  Y. Hayashi,et al.  Mutations of the GATA2 and CEBPA genes in paediatric acute myeloid leukaemia , 2014, British journal of haematology.

[103]  S. Miyano,et al.  The landscape of somatic mutations in Down syndrome–related myeloid disorders , 2013, Nature Genetics.

[104]  T. Suda,et al.  Haploinsufficiency of SAMD9L, an endosome fusion facilitator, causes myeloid malignancies in mice mimicking human diseases with monosomy 7. , 2013, Cancer cell.

[105]  N. Speck,et al.  Gata2 is required for HSC generation and survival , 2013, The Journal of experimental medicine.

[106]  J. Fitzgibbon,et al.  GATA2 mutations in sporadic and familial acute myeloid leukaemia patients with CEBPA mutations , 2013, British journal of haematology.

[107]  S. Savage,et al.  Updates on the biology and management of dyskeratosis congenita and related telomere biology disorders , 2013, Expert review of hematology.

[108]  Kirby D. Johnson,et al.  GATA2 haploinsufficiency caused by mutations in a conserved intronic element leads to MonoMAC syndrome. , 2013, Blood.

[109]  A. Kohlmann,et al.  GATA2 mutations are frequent in intermediate-risk karyotype AML with biallelic CEBPA mutations and are associated with favorable prognosis , 2013, Leukemia.

[110]  P. Rohrlich,et al.  High frequency of GATA2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome, myelodysplasia, and acute myeloid leukemia. , 2013, Blood.

[111]  J. D. Engel,et al.  Conditional Gata2 inactivation results in HSC loss and lymphatic mispatterning. , 2012, The Journal of clinical investigation.

[112]  A. Baruchel,et al.  High GATA2 expression is a poor prognostic marker in pediatric acute myeloid leukemia. , 2012, Blood.

[113]  E. Hoster,et al.  GATA2 zinc finger 1 mutations associated with biallelic CEBPA mutations define a unique genetic entity of acute myeloid leukemia. , 2012, Blood.

[114]  T. Vulliamy,et al.  Marked genetic heterogeneity in familial myelodysplasia/acute myeloid leukaemia , 2012, British journal of haematology.

[115]  J. Fitzgibbon,et al.  Germ-line GATA2 p.THR354MET mutation in familial myelodysplastic syndrome with acquired monosomy 7 and ASXL1 mutation demonstrating rapid onset and poor survival , 2012, Haematologica.

[116]  R. Pfundt,et al.  Revertant somatic mosaicism by mitotic recombination in dyskeratosis congenita. , 2012, American journal of human genetics.

[117]  J. Rosenfeld,et al.  Loss-of-function germline GATA2 mutations in patients with MDS/AML or MonoMAC syndrome and primary lymphedema reveal a key role for GATA2 in the lymphatic vasculature. , 2012, Blood.

[118]  Sahar Mansour,et al.  Mutations in GATA2 cause primary lymphedema associated with a predisposition to acute myeloid leukemia (Emberger syndrome) , 2011, Nature Genetics.

[119]  S. Holland,et al.  Successful allogeneic hematopoietic stem cell transplantation for GATA2 deficiency. , 2011, Blood.

[120]  Bernard Keavney,et al.  Exome sequencing identifies GATA-2 mutation as the cause of dendritic cell, monocyte, B and NK lymphoid deficiency. , 2011, Blood.

[121]  Smita Y. Patel,et al.  Mutations in GATA2 are associated with the autosomal dominant and sporadic monocytopenia and mycobacterial infection (MonoMAC) syndrome. , 2011, Blood.

[122]  Anna L. Brown,et al.  Heritable GATA2 Mutations Associated with Familial Myelodysplastic Syndrome and Acute Myeloid Leukemia , 2011, Nature Genetics.

[123]  A. Dutra,et al.  Myelodysplasia in autosomal dominant and sporadic monocytopenia immunodeficiency syndrome: diagnostic features and clinical implications , 2011, Haematologica.

[124]  F. Sigaux,et al.  Myelodysplasia and leukemia of Fanconi anemia are associated with a specific pattern of genomic abnormalities that includes cryptic RUNX1/AML1 lesions. , 2011, Blood.

[125]  L. Kiemeney,et al.  Cancer risk in patients with Noonan syndrome carrying a PTPN11 mutation , 2011, European Journal of Human Genetics.

[126]  N. McGovern,et al.  The human syndrome of dendritic cell, monocyte, B and NK lymphoid deficiency , 2011, The Journal of experimental medicine.

[127]  Leiliang Zhang,et al.  M062 Is a Host Range Factor Essential for Myxoma Virus Pathogenesis and Functions as an Antagonist of Host SAMD9 in Human Cells , 2011, Journal of Virology.

[128]  M. Loh,et al.  Germline CBL mutations cause developmental abnormalities and predispose to juvenile myelomonocytic leukemia , 2010, Nature Genetics.

[129]  B. Alter,et al.  Pathophysiology and management of inherited bone marrow failure syndromes. , 2010, Blood reviews.

[130]  M. Ballmaier,et al.  RAS and CSF3R mutations in severe congenital neutropenia. , 2009, Blood.

[131]  T. Inaba,et al.  Identification of a common microdeletion cluster in 7q21.3 subband among patients with myeloid leukemia and myelodysplastic syndrome. , 2009, Biochemical and biophysical research communications.

[132]  Mark George Thomas,et al.  Normophosphatemic familial tumoral calcinosis is caused by deleterious mutations in SAMD9, encoding a TNF-alpha responsive protein. , 2008, The Journal of investigative dermatology.

[133]  Saijuan Chen,et al.  Gain-of-function mutation of GATA-2 in acute myeloid transformation of chronic myeloid leukemia , 2008, Proceedings of the National Academy of Sciences.

[134]  D. Geiger,et al.  A deleterious mutation in SAMD9 causes normophosphatemic familial tumoral calcinosis. , 2006, American journal of human genetics.

[135]  T. Lister,et al.  Mutation of CEBPA in familial acute myeloid leukemia. , 2004, The New England journal of medicine.

[136]  H. Hoehn,et al.  Reverse mosaicism in Fanconi anemia: natural gene therapy via molecular self-correction , 2003, Cytogenetic and Genome Research.

[137]  P G Mori,et al.  Myelodysplasia syndrome and acute myeloid leukemia in patients with congenital neutropenia receiving G-CSF therapy. , 2000, Blood.

[138]  John M. Maris,et al.  Haploinsufficiency of CBFA2 causes familial thrombocytopenia with propensity to develop acute myelogenous leukaemia , 1999, Nature Genetics.

[139]  D Orlic,et al.  Enforced expression of the GATA-2 transcription factor blocks normal hematopoiesis. , 1999, Blood.

[140]  C. Mathew,et al.  Somatic Mosaicism in Fanconi Anemia: Molecular Basis and Clinical Significance , 1997, European journal of human genetics : EJHG.

[141]  Stuart H. Orkin,et al.  An early haematopoietic defect in mice lacking the transcription factor GATA-2 , 1994, Nature.

[142]  H. Böhles.  Die perniziöse Fanconi-Anämie, 1927 , 2020 .

[143]  S. Edkins,et al.  Gata2 as a Crucial Regulator of Stem Cells in Adult Hematopoiesis and Acute Myeloid Leukemia , 2019, Stem cell reports.

[144]  T. Marafioti,et al.  Can somatic GATA 2 mutation mimic germ line GATA 2 mutation ? , 2018 .

[145]  L. Bullinger,et al.  Clinical impact of GATA2 mutations in acute myeloid leukemia patients harboring CEBPA mutations: a study of the AML study group , 2016, Leukemia.

[146]  S. Holland,et al.  GATA2 deficiency-associated bone marrow disorder differs from idiopathic aplastic anemia. , 2015, Blood.

[147]  J. Merino,et al.  GATA 2 Germline Mutations Impair GATA 2 Transcription , Causing Haploinsufficiency : Functional Analysis of the p . Arg 396 Gln Mutation , 2015 .

[148]  T. Naoe,et al.  GATA2 zinc finger 2 mutation found in acute myeloid leukemia impairs myeloid differentiation. , 2013, Leukemia research reports.

[149]  P. Rohrlich,et al.  High frequency of GATA 2 mutations in patients with mild chronic neutropenia evolving to MonoMac syndrome , myelodysplasia , and acute myeloid leukemia * , 2013 .

[150]  M. Ballmaier,et al.  Incidence of CSF3R mutations in severe congenital neutropenia and relevance for leukemogenesis: Results of a long-term survey. , 2007, Blood.

[151]  Johanna M. Rommens,et al.  Mutations in SBDS are associated with Shwachman–Diamond syndrome , 2003, Nature Genetics.